Formulary
Dinutuximab beta [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Dinutuximab beta [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Dinutuximab beta [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Dinutuximab beta [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**Neuroblastoma**
- **Adult** (By Intravenous Infusion): Specialist drug - access specialist resources for dosing information.
Contraindications
For dinutuximab beta [Specialist drug] Acute grade 3 or 4, or extensive chronic graft-versus-host disease
Side effects
For dinutuximab beta [Specialist drug] Common or very common Anaemia; anxiety; appetite decreased; arthralgia; ascites; capillary leak syndrome; chest pain; chills; constipation; cough; cytokine release syndrome; decreased leucocytes; device related infection; diarrhoea; dizziness; dyspnoea; electrolyte imbalance; eye disorders; eye inflammation; fever; fluid imbalance; gastrointestinal discomfort; gastrointestinal disorders; haematuria; headache; heart failure; hyperhidrosis; hypersensitivity; hypertension; hypertriglyceridaemia; hypoalbuminaemia; hypotension; hypoxia; increased risk of infection; left ventricular dysfunction; muscle spasms; nausea; neutropenia; oedema; oral disorders; pain; paraesthesia; pericardial effusion; peripheral neuropathy; photosensitivity reaction; pulmonary oedema; renal impairment; respiratory disorders; seizure; sepsis; skin reactions; tachycardia; thrombocytopenia; tremor; urinary retention; urine abnormalities; vision disorders; vomiting; weight changes Uncommon Disseminated intravascular coagulation; eosinophilia; hepatocellular injury; hypovolaemic shock; intracranial pressure increased; peripheral vascular disease; posterior reversible encephalopathy syndrome (PRES) Frequency not known Erythropenia
Medicinal forms
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Dinutuximab beta [Specialist drug] in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

